Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants

This study evaluates the performance of the PanBio COVID-19 antigen (Ag) test as part of a hospital infection control policy. Hospital staff was encouraged to get tested for COVID-19 when presenting with SARS-CoV-2-related symptoms. In a period of approximately 5 months, a steady decline in the perf...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ogtrop, M. L., van de Laar, T. J. W., Eggink, D., Vanhommerig, J. W., van der Reijden, W. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612141/
https://www.ncbi.nlm.nih.gov/pubmed/34817226
http://dx.doi.org/10.1128/Spectrum.00884-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612141/
https://www.ncbi.nlm.nih.gov/pubmed/34817226
http://dx.doi.org/10.1128/Spectrum.00884-21

Ejemplares similares